BOSTON ADVISORS LLC - LEXICON PHARMACEUTICALS INC ownership

LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 139 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 6.44 and the average weighting 0.8%.

Quarter-by-quarter ownership
BOSTON ADVISORS LLC ownership history of LEXICON PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2017$524,000
+12.0%
31,855
-2.4%
0.01%
+9.1%
Q1 2017$468,000
+13.0%
32,655
+9.0%
0.01%
+10.0%
Q4 2016$414,000
+4.3%
29,960
+36.3%
0.01%0.0%
Q3 2016$397,00021,9800.01%
Other shareholders
LEXICON PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Ulys, L.L.C. 4,321,214$46,410,00099.99%
Artal Group S.A. 57,517,978$617,743,00013.80%
ACUTA CAPITAL PARTNERS, LLC 400,000$4,296,0002.49%
BRIDGER MANAGEMENT, LLC 1,292,368$13,880,0000.95%
Rhenman & Partners Asset Management AB 200,000$2,148,0000.34%
KINGDON CAPITAL MANAGEMENT, L.L.C. 525,000$5,639,0000.27%
KINGDON CAPITAL MANAGEMENT, L.L.C. 400,000$4,296,0000.21%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 35,714$384,0000.19%
MASTERS CAPITAL MANAGEMENT LLC 500,000$5,370,0000.18%
Round Table Services, LLC 21,611$232,0000.17%
View complete list of LEXICON PHARMACEUTICALS INC shareholders